CD274 and cancer: Blocking glutaminolysis in lung cancer cell lines results in upregulation of PD-L1 expression via NF-κB activity and dampened T-cell activation, but when glutaminolysis is inhibited together with PD-L1 blockade, the balance tips towards T-cell mediated cancer cell death (37).